
The study investigated bone metastasis induced by Notch signaling pathway dysregulation and demonstrated the potential therapeutic target of SPARC in adenoid cystic carcinoma (AdCC) with Notch dysregulation. The results showed that genes down-regulated in Notch-mutant AdCCs, such as SPARC, were enriched in ossification and osteoblast differentiation. NICD over-expression promoted cell growth, migration, and osteoclast differentiation, which could be partly reversed by exogenous SPARC. Therefore, the study suggests that SPARC may represent a prognostic biomarker and potential therapeutic target for AdCC with Notch dysregulation.
Like
Save
Share